Integrated BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 8, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	6	11	6	10	15	33
Market Cap Growth	-51.24%	75.42%	-36.28%	-33.74%	-54.33%	146.41%
Enterprise Value	3	9	6	10	19	41
Last Close Price	0.18	0.36	0.21	0.33	0.50	1.10
PE Ratio	-	13.72	56.44	-	3.90	4.09
PS Ratio	0.12	0.20	0.13	0.20	0.27	0.52
PB Ratio	0.30	0.55	0.33	0.53	0.81	2.29
P/TBV Ratio	0.30	0.55	0.33	0.53	0.81	2.29
P/FCF Ratio	1.98	5.92	16.21	8.89	4.15	11.90
P/OCF Ratio	1.86	5.37	6.70	8.05	3.66	10.75
EV/Sales Ratio	0.06	0.17	0.13	0.20	0.35	0.64
EV/EBITDA Ratio	53.12	3.96	11.36	21.85	6.31	6.68
EV/EBIT Ratio	-	4.59	25.26	85.75	7.08	7.07
EV/FCF Ratio	1.10	4.94	16.26	9.22	5.39	14.84
Debt / Equity Ratio	0.18	0.05	0.09	0.14	0.11	0.42
Debt / EBITDA Ratio	56.71	0.30	1.15	1.91	0.55	0.84
Debt / FCF Ratio	1.18	0.54	4.61	2.39	0.57	2.18
Net Debt / Equity Ratio	-0.13	-0.13	0.01	0.07	0.09	0.40
Net Debt / EBITDA Ratio	2.60	-1.11	0.22	2.88	0.56	0.94
Net Debt / FCF Ratio	-0.87	-1.39	0.31	1.22	0.48	2.08
Asset Turnover	1.84	2.13	1.95	2.00	2.22	2.63
Inventory Turnover	5.06	4.74	4.32	4.37	4.37	4.96
Quick Ratio	1.72	2.13	1.04	1.21	0.99	0.66
Current Ratio	3.25	4.42	2.92	3.39	3.16	1.95
Return on Equity (ROE)	-8.40%	4.08%	0.59%	-0.18%	23.33%	78.55%
Return on Assets (ROA)	-2.98%	4.94%	0.61%	0.30%	6.77%	14.94%
Return on Invested Capital (ROIC)	-7.93%	4.27%	0.53%	-0.20%	13.61%	31.50%
Return on Capital Employed (ROCE)	-5.90%	9.80%	1.20%	0.60%	13.70%	35.70%
Earnings Yield	-29.46%	7.29%	1.77%	-0.34%	25.64%	24.44%
FCF Yield	50.57%	16.90%	6.17%	11.25%	24.08%	8.40%
Buyback Yield / Dilution	1.92%	-0.95%	-3.08%	7.34%	-0.65%	-3.07%